A Feasibility Phase II Study in the Treatment of Resected Cholangiocarcinoma, Gallbladder, Pancreatic and Ampullary Cancers
Status:
Completed
Trial end date:
2012-09-01
Target enrollment:
Participant gender:
Summary
To assess the feasibility of administering induction chemotherapy with gemcitabine and
docetaxel followed by concurrent radiation and continuous infusion 5FU and consolidation
gemcitabine/docetaxel chemotherapy.